rs72657389

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001277115.2(DNAH11):​c.9935A>T​(p.Asp3312Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00329 in 1,569,876 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. D3312D) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0031 ( 3 hom., cov: 31)
Exomes 𝑓: 0.0033 ( 11 hom. )

Consequence

DNAH11
NM_001277115.2 missense

Scores

2
6
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: 8.70

Publications

6 publications found
Variant links:
Genes affected
DNAH11 (HGNC:2942): (dynein axonemal heavy chain 11) This gene encodes a ciliary outer dynein arm protein and is a member of the dynein heavy chain family. It is a microtubule-dependent motor ATPase and has been reported to be involved in the movement of respiratory cilia. Mutations in this gene have been implicated in causing Kartagener Syndrome (a combination of situs inversus totalis and Primary Ciliary Dyskinesia (PCD), also called Immotile Cilia Syndrome 1 (ICS1)) and male sterility. [provided by RefSeq, Mar 2013]
DNAH11 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0102032125).
BP6
Variant 7-21789251-A-T is Benign according to our data. Variant chr7-21789251-A-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 163118.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00312 (475/152208) while in subpopulation NFE AF = 0.00413 (281/68002). AF 95% confidence interval is 0.00374. There are 3 homozygotes in GnomAd4. There are 256 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH11NM_001277115.2 linkc.9935A>T p.Asp3312Val missense_variant Exon 61 of 82 ENST00000409508.8 NP_001264044.1 Q96DT5Q96NT7H9NAJ8H9NAJ7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH11ENST00000409508.8 linkc.9935A>T p.Asp3312Val missense_variant Exon 61 of 82 5 NM_001277115.2 ENSP00000475939.1 Q96DT5

Frequencies

GnomAD3 genomes
AF:
0.00313
AC:
476
AN:
152090
Hom.:
3
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000700
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00380
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00207
Gnomad FIN
AF:
0.00829
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00413
Gnomad OTH
AF:
0.00383
GnomAD2 exomes
AF:
0.00362
AC:
672
AN:
185544
AF XY:
0.00344
show subpopulations
Gnomad AFR exome
AF:
0.000756
Gnomad AMR exome
AF:
0.00388
Gnomad ASJ exome
AF:
0.000336
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00891
Gnomad NFE exome
AF:
0.00360
Gnomad OTH exome
AF:
0.00811
GnomAD4 exome
AF:
0.00330
AC:
4684
AN:
1417668
Hom.:
11
Cov.:
30
AF XY:
0.00328
AC XY:
2298
AN XY:
700770
show subpopulations
African (AFR)
AF:
0.000494
AC:
16
AN:
32416
American (AMR)
AF:
0.00401
AC:
153
AN:
38136
Ashkenazi Jewish (ASJ)
AF:
0.000355
AC:
9
AN:
25344
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37518
South Asian (SAS)
AF:
0.00258
AC:
207
AN:
80156
European-Finnish (FIN)
AF:
0.00818
AC:
415
AN:
50758
Middle Eastern (MID)
AF:
0.00384
AC:
22
AN:
5722
European-Non Finnish (NFE)
AF:
0.00337
AC:
3671
AN:
1088780
Other (OTH)
AF:
0.00325
AC:
191
AN:
58838
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
213
425
638
850
1063
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
126
252
378
504
630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00312
AC:
475
AN:
152208
Hom.:
3
Cov.:
31
AF XY:
0.00344
AC XY:
256
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.000698
AC:
29
AN:
41538
American (AMR)
AF:
0.00373
AC:
57
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00207
AC:
10
AN:
4822
European-Finnish (FIN)
AF:
0.00829
AC:
88
AN:
10610
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00413
AC:
281
AN:
68002
Other (OTH)
AF:
0.00379
AC:
8
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
25
49
74
98
123
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00311
Hom.:
2
Bravo
AF:
0.00250
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.00285
AC:
11
ESP6500AA
AF:
0.000264
AC:
1
ESP6500EA
AF:
0.00402
AC:
33
ExAC
AF:
0.00255
AC:
304
Asia WGS
AF:
0.00289
AC:
10
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Mar 21, 2024
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Has been previously reported as a likely benign and benign variant (PMID: 30819905, 22184204); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 22184204, 33111339, 30819905) -

Apr 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

DNAH11: BP4, BS2 -

not specified Benign:2
Sep 30, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Asp3312Val in exon 61 of DNAH11: This variant is not expected to have clinical significance because it has been identified in 0.7% (88/12864) of European chro mosomes, including 1 homozygote by the Exome Aggregation Consortium (ExAC, http: //exac.broadinstitute.org; dbSNP rs72657389). -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia 7 Benign:2
Oct 21, 2022
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Primary ciliary dyskinesia Benign:1
Dec 08, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.11
CADD
Uncertain
23
DANN
Benign
0.95
DEOGEN2
Uncertain
0.50
.;.;D
Eigen
Uncertain
0.57
Eigen_PC
Uncertain
0.65
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.95
D;D;D
MetaRNN
Benign
0.010
T;T;T
MetaSVM
Uncertain
-0.27
T
PhyloP100
8.7
PrimateAI
Benign
0.46
T
PROVEAN
Pathogenic
-7.4
.;D;.
REVEL
Uncertain
0.54
Sift
Benign
0.29
.;T;.
Vest4
0.53
MVP
0.80
ClinPred
0.082
T
GERP RS
6.2
Varity_R
0.58
gMVP
0.49
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72657389; hg19: chr7-21828869; COSMIC: COSV60987029; API